From April 1, 2024 to April 9, 2024, the company has repurchased 600,000 shares, representing 0.11% for CNY 10.48 million. With this, the company has completed the repurchase of 1,260,000 shares, representing 0.23% for CNY 29.87 million under the buyback announced on October 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.97 CNY | +1.64% | +6.90% | -28.55% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.55% | 1.34B | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.